TheProfitWatch

CORT - Corcept Therapeutics Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
75.1 2.38 (3.17%) -0.02 (-0.02%) 0.01 (0.01%) -0.76 (-0.97%) --- 2.38 (3.17%) --- ---

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.33
Diluted EPS:
0.29
Basic P/E:
234.7879
Diluted P/E:
267.1724
RSI(14) 1m:
40.28
VWAP:
77.5
RVol:

Events

Period Kind Movement Occurred At

Related News